European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Lilly Industries Ltd., Basingstoke

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Lilly Industries Ltd.
Eli Lilly and Company Ltd.

Register

Chp
Companies House 00757048

Address

Basingview, Eli Lilly And Company Limited, Lilly House, Basingstoke RG21 4FA, United Kingdom

Additional info

21.10
Manufacture of basic pharmaceutical products

Financials

History

Marketing & Tech

Network

Loading network
CSV export

Quarterly Exports in CSV

Now available in CSV format and optimized for applications in AI and Analytics:
North Data's quarterly exports have become the industry standard for company information.

Publications

24 Nov 2023 also 22/11/2022, 15/11/2021, 03/12/2020, 15/11/2019, 13/11/2018, 15/12/2017
Confirmation statement made with no updates
23 Sept 2023 also 12/09/2022, 04/10/2021, 29/09/2020, 12/09/2019, 01/10/2018, 01/09/2017, 13/10/2016, 08/10/2015, 22/09/2014, 17/09/2013, 27/09/2012, 29/09/2011, 25/09/2010, 26/10/2009, 02/10/2008, 28/02/2007, 22/09/2006, 01/12/2005
Accounts for a dormant company made up to 2022-12-31
16 Feb 2023
Director: Yuya Nonaka
15 Feb 2023
No longer Director: Michael Czapar
25 Oct 2021 as Eli Lilly AND Company Ltd.
Wordmark: “FIDAVET FIBERDYN“
26 Jul 2021
Appointment of Ms Laura Demayo Steele as a director
23 Jul 2021
Change of details for Eli Lilly and Company Limited as a person with significant control
22 Jul 2021
Address
16 Feb 2021
No longer Director: Hamish J. C. Bennett · No longer Secretary: Hamish J. C. Bennett
4 Jan 2021
Director: Michael Czapar · No longer Director: Nicholas Lemen
Year 2020 in Hor
6 EU fundings (€0.00): Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment …
1 May 2020 as Eli Lilly AND Company Ltd.
Wordmark: “SYNCORIS“
Year 2019 in Hor
9 EU fundings (€0.00): Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases …
6 Dec 2018
Director: Nicholas Lemen
5 Dec 2018
No longer Director: Rebecca Anne Morison
Year 2018 in Hor
7 EU fundings (€0.00): European Health Data and Evidence Network …
1 Aug 2018 in Fts
EU funding (€263,861): 764860 - Tobeatpain - Targeting Neuroinflammation to Combat Pathological Pain in Neurodegenerative Diseases and Chronic Pain Syndromes
Year 2017 in Hor
5 EU fundings (€0.00): Liver Investigation: Testing Marker Utility in Steatohepatitis …
24 Nov 2016
Confirmation statement made with updates
Year 2016 in Hor
7 EU fundings (€0.00): Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 …
7 Jul 2016
Director: Rebecca Anne Morison
6 May 2016
Director: Hamish J. C. Bennett · Secretary: Hamish J. C. Bennett
5 May 2016
No longer Director: Susan Dawn Pezzack · No longer Secretary: Susan Dawn Pezzack
23 Nov 2015
Capital: £100.00
1 Nov 2015 in Hor
EU funding: Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797
1 Jul 2015 in Hor
EU funding: Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890
1 May 2015 in Fts
EU funding (€1,245,000): 634893 - Regain - Regeneration of Inner EAR Hair Cells with Gamma-Secretase Inhibitors to Regain Hearing in Patients with Sensorineural Hearing Loss
1 May 2015 in Hor
EU funding (€1,347,363): REgeneration of inner ear hair cells with GAmma-secretase INhibitors to regain hearing in patients with sensorineural hearing loss
24 Nov 2014
Capital: £100.00
1 Oct 2014 in Fts
EU funding (€283,582): Diagnostic and Drug Discovery Initiative for Alzheimer's Disease
7 Mar 2014
Director: Susan Dawn Pezzack · Secretary: Susan Dawn Pezzack · No longer Director (1)
1 Feb 2014 in Fts
EU funding (€124,558): Psyscan
19 Nov 2013
Capital: £100.00
19 Dec 2012
No longer Director (1)
18 Dec 2012
Appointment of Mr Jean-Michel Yves, Sylvain Cossery as a director
14 Nov 2012 also 11/11/2011
Annual return made up to 2012-11-11 with full list of shareholders
22 Jun 2011
Secretary (1) · No longer Secretary (1)
9 Nov 2010 also 21/12/2009
Annual return made up to 2010-11-05 with full list of shareholders
22 Jan 2010
Director (1) · No longer Director (1)
18 Dec 2009
No longer Secretary (1)
1 May 2009
Secretary (1)
19 Nov 2008 also 30/11/2007, 16/01/2007
Return made up to 05/11/08; full list of members
12 Sept 2008
Secretary (1) · No longer Secretary (1)
5 Jul 2007 also 13/06/2006
New secretary appointed
4 Jul 2007 also 09/06/2006
Secretary resigned
12 Jan 2007
Address
28 Jun 2006 as Eli Lilly AND Company Ltd.
Patent: Use of Crystal Forms of 2-Methyl-Thieno-Benzodiazepine
5 Apr 2006
New director appointed
3 Apr 2006
Director resigned
9 Nov 2005
Address

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "Lilly Industries Ltd., Basingstoke" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close